These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 19563342

  • 21. Mesenchymal stem cells alleviate acute kidney injury by down-regulating C5a/C5aR pathway activation.
    Tang M, Zhang K, Li Y, He QH, Li GQ, Zheng QY, Zhang KQ.
    Int Urol Nephrol; 2018 Aug; 50(8):1545-1553. PubMed ID: 29594894
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. C3 promotes expansion of CD8+ and CD4+ T cells in a Listeria monocytogenes infection.
    Nakayama Y, Kim SI, Kim EH, Lambris JD, Sandor M, Suresh M.
    J Immunol; 2009 Sep 01; 183(5):2921-31. PubMed ID: 19648268
    [Abstract] [Full Text] [Related]

  • 25. Combination of decay-accelerating factor expression and alpha1,3-galactosyltransferase knockout affords added protection from human complement-mediated injury.
    van Denderen BJ, Salvaris E, Romanella M, Aminian A, Katerelos M, Tange MJ, Pearse MJ, d'Apice AJ.
    Transplantation; 1997 Sep 27; 64(6):882-8. PubMed ID: 9326415
    [Abstract] [Full Text] [Related]

  • 26. Systemic C3 modulates CD8+ T cell contraction after Listeria monocytogenes infection.
    Tan Y, Li Y, Fu X, Yang F, Zheng P, Zhang J, Guo B, Wu Y.
    J Immunol; 2014 Oct 01; 193(7):3426-35. PubMed ID: 25187659
    [Abstract] [Full Text] [Related]

  • 27. Targeted Complement Inhibition Protects Vascularized Composite Allografts From Acute Graft Injury and Prolongs Graft Survival When Combined With Subtherapeutic Cyclosporine A Therapy.
    Zhu P, Bailey SR, Lei B, Paulos CM, Atkinson C, Tomlinson S.
    Transplantation; 2017 Apr 01; 101(4):e75-e85. PubMed ID: 28045880
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Complement factor C5a induces atherosclerotic plaque disruptions.
    Wezel A, de Vries MR, Lagraauw HM, Foks AC, Kuiper J, Quax PH, Bot I.
    J Cell Mol Med; 2014 Oct 01; 18(10):2020-30. PubMed ID: 25124749
    [Abstract] [Full Text] [Related]

  • 30. C5a and bradykinin receptor cross-talk regulates innate and adaptive immunity in Trypanosoma cruzi infection.
    Schmitz V, Almeida LN, Svensjö E, Monteiro AC, Köhl J, Scharfstein J.
    J Immunol; 2014 Oct 01; 193(7):3613-23. PubMed ID: 25187655
    [Abstract] [Full Text] [Related]

  • 31. Signaling through C5a receptor and C3a receptor diminishes function of murine natural regulatory T cells.
    Kwan WH, van der Touw W, Paz-Artal E, Li MO, Heeger PS.
    J Exp Med; 2013 Feb 11; 210(2):257-68. PubMed ID: 23382542
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Time-dependent C5a and C5aR expression in dental pulp cells following stimulation with LTA and LPS.
    Liu M, Mu H, Peng W, Zhao L, Hu W, Jiang Z, Gao L, Cao X, Li N, Han J.
    Int J Mol Med; 2019 Sep 11; 44(3):823-834. PubMed ID: 31257457
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. A Novel Role for C5a in B-1 Cell Homeostasis.
    Bröker K, Figge J, Magnusen AF, Manz RA, Köhl J, Karsten CM.
    Front Immunol; 2018 Sep 11; 9():258. PubMed ID: 29520270
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. bFGF and VEGF synergistically enhance endothelial cytoprotection via decay-accelerating factor induction.
    Mason JC, Lidington EA, Ahmad SR, Haskard DO.
    Am J Physiol Cell Physiol; 2002 Mar 11; 282(3):C578-87. PubMed ID: 11832343
    [Abstract] [Full Text] [Related]

  • 38. Complement therapeutics meets nanomedicine: overcoming human complement activation and leukocyte uptake of nanomedicines with soluble domains of CD55.
    Gifford G, Vu VP, Banda NK, Holers VM, Wang G, Groman EV, Backos D, Scheinman R, Moghimi SM, Simberg D.
    J Control Release; 2019 May 28; 302():181-189. PubMed ID: 30974134
    [Abstract] [Full Text] [Related]

  • 39. Modulation of the antitumor immune response by complement.
    Markiewski MM, DeAngelis RA, Benencia F, Ricklin-Lichtsteiner SK, Koutoulaki A, Gerard C, Coukos G, Lambris JD.
    Nat Immunol; 2008 Nov 28; 9(11):1225-35. PubMed ID: 18820683
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.